2 Unreasonably Battered Stocks I’d Buy Before They

2 Unreasonably Battered Stocks I’d Buy Before They Can Correct to the Upside

Motley Fool

Published 16 Jul 2020

BlackBerry Ltd. (TSX:BB)(NYSE:BB) and another deep value stock could give value investors a huge bang for their invested buck.

The post 2 Unreasonably Battered Stocks I’d Buy Before They Can Correct to the Upside appeared first on The Motley Fool Canada.

Full Article

2 Unreasonably Battered Stocks I’d Buy Before They Can Correct to the Upside

2 Unreasonably Battered Stocks I’d Buy Before They Can Correct to the Upside

You might like

Related news coverage

'Pandemic and advertiser boycott create heightened uncertainty': Here's what 3 analysts expect from Facebook's quarterly earnings

'A key beneficiary of shelter-in-place and work from home': Here's what 4 analysts are saying ahead of Amazon's quarterly earnings (AMZN)

Portfolio manager Jason Tauber is outstripping the market's returns in 2020. He says these 3 high-growth companies have 'hidden assets' that could make them far more valuable than most investors believe.

200-plus money managers pay thousands to set eyes on Jim Osman's stock buy list. Here are 2 he says are set to soar — and an under-the-radar IPO to keep a watch on

Morgan Stanley boosts Tesla bull case to 65% upside, but still has an 'underweight' rating on the automaker's shares (TSLA)

Advertisement

More coverage

3 Wall Street pros managing $12 billion in assets share their strategies for profiting from the economy's recovery — and explain why investors should be aggressively taking risks now

Bitcoin's rally above $11,000 is exactly what crypto bulls are looking for, Oppenheimer's technical analysis head says

Shares of Docusign, Twilio and Zendesk have soared in the COVID-19 crisis -- and they'll likely continue rallying, according to a JMP Securities analyst who has a 'buy' rating to the stocks (ZEN, TWLO, DOCU)

Bernstein downgrades Tesla and says the stock will tank 42% from its 'mind-boggling' valuation

Morgan Stanley double-upgrades Biogen and says the stock can surge another 30% (BIIB)